Vitamin D hormones. 2.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001581:Benzothiadiazines; D001847:Bone Diseases / Q000378:metabolism; D001842:Bone and Bones / Q000187:drug effects; D001943:Breast Neoplasms / Q000378:metabolism; D002648:Child; D004232:Diuretics; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D006934:Hypercalcemia / Q000209:etiology; D007015:Hypophosphatemia, Familial / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008297:Male; D011453:Prostaglandins / Q000494:pharmacology; D012507:Sarcoidosis / Q000378:metabolism; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects; D014807:Vitamin D / Q000378:metabolism*
D000305:Adrenal Cortex Hormones; D000927:Anticonvulsants; D000970:Antineoplastic Agents; D001581:Benzothiadiazines; D004232:Diuretics; D004967:Estrogens; D006887:Hydroxycholecalciferols; D011453:Prostaglandins; D049993:Sodium Chloride Symporter Inhibitors; D014807:Vitamin D